Browse Category

Policy Analysis News 4 December 2025 - 21 December 2025

Eli Lilly Stock Week Ahead (Dec. 22–26, 2025): LLY Enters Holiday Week With Obesity-Drug Catalysts, Pricing Headlines, and Policy Risk

Eli Lilly Stock Week Ahead (Dec. 22–26, 2025): LLY Enters Holiday Week With Obesity-Drug Catalysts, Pricing Headlines, and Policy Risk

As of Sunday, December 21, 2025, Eli Lilly and Company (NYSE: LLY) heads into a holiday-shortened trading week near recent highs, after a busy stretch of headlines spanning next-generation obesity drugs, potentially accelerated FDA review timelines, price cuts aimed at
21 December 2025
Shanghai Stock Exchange Update (Dec. 21, 2025): Shanghai Composite Near 3,900 as Policy Watch Meets STAR Market AI-IPO Boom

Shanghai Stock Exchange Update (Dec. 21, 2025): Shanghai Composite Near 3,900 as Policy Watch Meets STAR Market AI-IPO Boom

The Shanghai Stock Exchange (SSE) heads into the final full trading stretch of 2025 with two stories unfolding at once: a steadier, policy-sensitive main board and a turbo-charged STAR Market where “hard tech” listings—especially AI chipmakers—are setting the tone for
Shenzhen Stock Exchange News: ChiNext Holds Gains as Vanke Debt Talks, Delistings and 2026 Policy Outlook Shape Sentiment (Dec 20, 2025)

Shenzhen Stock Exchange News: ChiNext Holds Gains as Vanke Debt Talks, Delistings and 2026 Policy Outlook Shape Sentiment (Dec 20, 2025)

SHENZHEN / BEIJING — December 20, 2025. The Shenzhen Stock Exchange (SZSE) is closed on Saturday, but the story of Shenzhen-listed equities is still moving—because the most important forces driving prices right now are not limited to the trading day.
China Stock Market Week Ahead (Dec 15–19, 2025): Shanghai & Shenzhen Outlook After Beijing’s 2026 Policy Signals

China Stock Market Week Ahead (Dec 15–19, 2025): Shanghai & Shenzhen Outlook After Beijing’s 2026 Policy Signals

Updated: December 14, 2025 Mainland China’s stock market heads into the new week with a familiar tug-of-war: supportive policy messaging versus still-stubborn evidence of weak domestic demand—especially in property and household credit. By Friday’s close (Dec 12), the Shanghai Composite finished at 3,889.35,
14 December 2025
Oscar Health (OSCR) Stock Today: Fresh Analyst Coverage, Big 2027 Profit Hopes and Policy Risk in Focus

Oscar Health (OSCR) Stock Today: Fresh Analyst Coverage, Big 2027 Profit Hopes and Policy Risk in Focus

Oscar Health, Inc. (NYSE: OSCR) is back under the market’s spotlight on December 11, 2025, as Wall Street adds new coverage, doubles down on long‑term profit targets, and investors digest another bout of volatility in this high‑growth, high‑risk health‑insurtech name.
Go toTop